BioSpace News Archive

Deals

ICON’s Acquisition of Symphony Clinical Research

Acquisition enhances ICON’s ability to offer customers hybrid trial solutions and site support services

October 23, 2019
·
4 min read
Pharm Country

IsoPlexis Receives $2 Million National Cancer Institute Grant to Target the Functional Pathways in Rare Cancer Cells that Drive Resistance

IsoPlexis, the leading life sciences company in the single-cell proteomics space, announced today that it has received $2 million in grant funding from the National Cancer Institute’s Small Business Innovation Research (NCI SBIR) Development Center for the advancement of intracellular proteomic pathway targeting solutions for single tumor cell analyses.

October 23, 2019
·
1 min read
Pharm Country

ECRI Institute: Diagnostic Tests, Medication Pose Biggest Risks to Patients in Ambulatory Care

New research from ECRI Institute, the nation’s leading independent, non-profit patient safety organization, reveals that diagnostic testing and medication events are the most frequent safety risks patients face in ambulatory care.

October 23, 2019
·
3 min read
Business

ABC Financial and Trek Announce Vendor Partnership

ABC Financial (ABC), the leading software and payment processing provider to the health and fitness industry, today announced their preferred partnership with Trek CCM, LLC.

October 23, 2019
·
2 min read
Biotech Beach

Ambry Genetics Published Data that Finds Adding RNA Genetic Testing Provides More Accurate, Actionable Results for Patients who Receive DNA Testing for Hereditary Cancer Risk

Ambry Genetics® (Ambry), a leading clinical genetics company, announced today the publication in JAMA Network Open of a study on retrospective RNA genetic testing for hereditary cancer risk

October 23, 2019
·
4 min read
Business

CVS Health Corporation To Hold Third Quarter 2019 Conference Call

CVS Health Corporation will hold a conference call with analysts and investors on Wednesday, November 6, 2019, at 8:00 a.m. to discuss its financial results for the third quarter of 2019.

October 23, 2019
·
1 min read
HEXO Corp announces $70 million private placement of convertible debentures led by Directors, CEO, and long-term shareholders; reschedules FY 2019 earnings call

HEXO Corp (“HEXO” or the “Company”) (TSX:HEXO; NYSE:HEXO) today announced that it has entered into subscription agreements with a group of investors pursuant to which the investors have agreed to purchase, on a private placement basis, $70 million principal amount of 8.0% unsecured convertible debentures of the Company (the “Debentures”).

October 23, 2019
·
6 min read
FDA

FDA grants “Breakthrough Device Designation” to CorFlow Therapeutics to expedite clinical development and regulatory review of its CoFI™ (COF-fee) System

The MOCA I trial is a safety and feasibility trial in 40 acute heart attack patients.

October 23, 2019
·
2 min read
BioMidwest

Herzing University Partners with National Association of Hispanic Nurses

University offers multiple pathways for nurses to earn additional degrees

October 23, 2019
·
3 min read
Deals

Chardan Healthcare Acquisition Corp. Shareholders Approve Definitive Merger Agreement with BiomX Ltd.

Combined Company Expected to Be Listed on the NYSE American Stock Exchange Under Symbols PHGE, PHGE.U, and PHGE.WS

October 23, 2019
·
7 min read